BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Katsunori Iijima. NSAIDs and Aspirin2016; : 143 doi: 10.1007/978-3-319-33889-7_10
2
Anca Negovan, Mihaela Iancu, Valeriu Moldovan, Kinga Sàrkàny, Simona Bataga, Simona Mocan, Ioan Țilea, Claudia Banescu. The contribution of clinical and pathological predisposing factors to severe gastro-duodenal lesions in patients with long-term low-dose aspirin and proton pump inhibitor therapyEuropean Journal of Internal Medicine 2017; 44: 62 doi: 10.1016/j.ejim.2017.05.017
3
Anca Negovan, Mihaela Iancu, Valeriu Moldovan, Septimiu Voidazan, Simona Bataga, Monica Pantea, Kinga Sarkany, Cristina Tatar, Simona Mocan, Claudia Banescu. Clinical Risk Factors for Gastroduodenal Ulcer in Romanian Low-Dose Aspirin ConsumersGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/7230626
4
Jin Sung Koh, Moon Kyung Joo. The Role of Helicobacter pylori Infection in Drug-induced Peptic UlcerThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2018; 18(2): 89 doi: 10.7704/kjhugr.2018.18.2.89
5
Ezekiel Uba Nwose, Kwang Choon Yee. Drug-disease interactions: narrative review of aspirin in gastric ulcerExpert Opinion on Drug Metabolism & Toxicology 2016; 12(9): 1081 doi: 10.1080/17425255.2016.1201064
6
Katsunori Iijima. IV. How Does the Etiology of Peptic Ulcers Change in Post-<i>Helicobacter pylori</i> Era?Nihon Naika Gakkai Zasshi 2017; 106(1): 33 doi: 10.2169/naika.106.33
7
Yan Zhang, Xiang-Ming Fang, Guo-Xun Chen. Clinical use of low-dose aspirin for elders and sensitive subjectsWorld Journal of Clinical Cases 2019; 7(20): 3168-3174 doi: 10.12998/wjcc.v7.i20.3168